Task force supports women collecting own samples for cervical cancer screening
In guidelines that may encourage more women to get screened for cervical cancer, a leading health task force has backed giving women over 30 the option to collect their own vaginal samples for testing.
Health panel endorses new option for cervical cancer screening
Starting at age 30, women can collect their own vaginal samples at a doctor's office instead of undergoing a pelvic exam for cervical cancer risk.
Self-testing option for cervical cancer screening endorsed by U.S. health panel
A pair of tests approved by the FDA in July give women the opportunity to collect their own samples in medical settings – similar to the way urine tests are handled.
HPV testing preferred over Pap for cervical cancer screening starting at age 30, task force’s draft recommendation says
Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new draft recommendation from the US Preventive Services Task Force.
US health panel adds self-testing option for cervical cancer screening
Women in their 20s should still get a Pap test every three years. But after that — from age 30 to 65 — women can get an HPV test every five years, the panel said.
Self-tests recommended for women ages 30 to 65 to screen for cervical cancer
The U.S. Preventive Services Task Force said the draft recommendations aim to avoid unnecessary follow-up tests and procedures.
U.S. Preventative Services Task Force endorses self-screen cervical cancer test
The goal is to get more people screened with more privacy and less discomfort. Patients can still request a traditional pap test performed by their doctor.
New draft recommendations for cervical cancer screening: 5 details
Routine cervical cancer screening typically requires patients to receive Pap smears every three years. On Dec. 10, a national task force put forth a new screening recommendation for women 30 and older: HPV testing every five years with the option to self-collect their sample.
USPSTF Issues Draft Recommendation Statement for Cervical Cancer Screening
The U.S. Preventive Services Task Force (USPSTF) recommends screening for cervical cancer, with different approaches recommended for those aged 21 to 29 years and 30 to 65 years. These recommendations form the basis of a draft recommendation statement published online Dec.
Health panel recommends self-testing option for cervical cancer screening
Women and people with cervixes should have the option to use a self-swab human papillomavirus (HPV) test as part of a cervical cancer screen, the United States Preventative Services Task Force said in a draft recommendation Tuesday.
Pap Smears May No Longer Be Part of Your Gyno Visit
The U.S. Preventive Services Task Force has introduced a new recommendation that women should undergo HPV testing every five ...
One-third of Americans uninformed about and undervaccinated for HPV, according to study
The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to ...
Science Daily1d
Americans are uninformed about and undervaccinated for HPV
Research shows that HPV accounts for 70% of all throat cancers, but only one-third of the public is aware that HPV causes throat cancer.
Medscape2d
Human Papillomavirus E6/E7 mRNA Testing as a Predictive Marker for Cervical Carcinoma
Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...
Wyoming News1d
Task Force Supports Women Over 30 Collecting Samples for Cervical Cancer Screening
In guidelines that may encourage more women to get screened for cervical cancer, a leading health task force has backed ...
News Medical1d
Public awareness and HPV vaccination rates remain low among American adults
The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to the National Cancer Institute.